![]() |
市場調查報告書
商品編碼
2019035
酵素改質寡糖市場:商業機會、成長要素、產業趨勢分析及2026-2035年預測。Enzymatically Modified Oligosaccharides Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
預計到 2025 年,全球酵素改性寡糖市場價值將達到 62 億美元,並有望以 8.1% 的複合年成長率成長,到 2035 年達到 135 億美元。

市場成長主要受食品飲料、營養補充品和嬰幼兒食品中功能性成分和益生元成分需求不斷成長的驅動。酵素處理低聚醣因其促進腸道健康、改善消化功能和增強免疫系統的功效而廣受認可。消費者對預防醫學、潔淨標示產品和功能性營養的日益關注,促使生產商將寡糖應用於更廣泛的領域。此外,酵素加工技術的進步提高了產品的純度、功能性和成本效益,進一步加速了其在已開發國家和新興市場的滲透。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 上市時的市場規模 | 62億美元 |
| 預測金額 | 135億美元 |
| 複合年成長率 | 8.1% |
按應用領域分類,預計2025年,食品飲料產業將佔銷售額的59.6%,成為市場佔有率最大的產業。酵素處理低聚醣廣泛應用於烘焙產品、乳製品、嬰幼兒配方奶粉、糖果甜點和機能飲料中,可在不影響口感或質地的前提下提升營養價值。為響應消費者不斷變化的飲食偏好,食品生產商正擴大利用這些成分開發低糖、高纖維和有益腸道健康的食品。監管機構核准將低聚醣用作機能性食品配料,進一步推動了其應用,使食品飲料行業成為市場上最大的應用領域。
預計到2025年,半乳寡糖(GOS)市佔率將達到22.5%,並在2035年之前以7.9%的複合年成長率成長。 GOS日益廣泛應用於嬰幼兒營養、膳食補充劑、機能性食品和乳製品等領域。這些透過酵素法處理乳糖而製成的化合物,因其益生元功效、支持腸道有益菌群的能力以及優於合成替代品的安全性而廣受認可。消費者對先進嬰幼兒營養解決方案的需求不斷成長,以及對消化系統健康意識的提高,正顯著推動GOS在各類食品和營養產品中的應用。
預計2026年至2035年,北美酵素改性寡醣市場將以8.4%的複合年成長率成長。這一成長得益於永續加工技術的持續進步,特別是酶改性技術的進步,這些技術與潔淨標示和功能性成分的發展趨勢相契合。消費者對天然來源、健康產品的偏好日益成長,以及對人工甜味劑的擔憂不斷加劇,促使製造商轉向富含益生元的配方。因此,各公司正在擴大低聚醣類成分在食品、膳食補充劑和藥品領域的應用,進一步加速了整個市場的發展。
The Global Enzymatically Modified Oligosaccharides Market was valued at USD 6.2 billion in 2025 and is estimated to grow at a CAGR of 8.1% to reach USD 13.5 billion by 2035.

Market growth is driven by increasing demand for functional and prebiotic ingredients in food, beverages, dietary supplements, and infant nutrition. Enzymatically modified oligosaccharides are widely recognized for their ability to promote gut health, improve digestive function, and support immune system performance. Rising consumer awareness regarding preventive healthcare, clean-label products, and functional nutrition is encouraging manufacturers to incorporate oligosaccharides into a broad range of applications. Additionally, advancements in enzymatic processing technologies are enabling higher purity, improved functionality, and cost-efficient production, further accelerating market adoption across developed and emerging economies.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $6.2 Billion |
| Forecast Value | $13.5 Billion |
| CAGR | 8.1% |
Based on application, the food & beverages segment held 59.6% share in 2025, accounting for the highest revenue share. Enzymatically modified oligosaccharides are widely used in bakery products, dairy formulations, infant formula, confectionery, and functional beverages to improve nutritional value without compromising taste or texture. Food manufacturers are increasingly leveraging these ingredients to develop low-sugar, high-fiber, and gut-health-focused products in response to shifting consumer dietary preferences. Regulatory approvals supporting the use of oligosaccharides as functional food ingredients are further driving adoption, making food and beverages the largest application segment in the market.
The galactooligosaccharides (GOS) segment held 22.5% share in 2025, and is projected to grow at a CAGR of 7.9% through 2035. GOS is increasingly being incorporated across sectors such as infant nutrition, dietary supplements, functional foods, and dairy applications. Produced from lactose through enzymatic processes, these compounds are widely recognized for their prebiotic benefits, ability to support beneficial gut bacteria, and favorable safety profile compared to synthetic alternatives. Rising demand for advanced infant nutrition solutions, along with growing consumer awareness around digestive health, is significantly boosting the adoption of GOS across a wide range of food and nutrition products.
North America Enzymatically Modified Oligosaccharides Market is anticipated to grow at a CAGR of 8.4% between 2026 and 2035. This growth is supported by ongoing advancements in sustainable processing technologies, particularly enzymatic modification methods that align with clean-label and functional ingredient trends. Increasing consumer preference for natural, health-focused products and rising concerns over artificial sweeteners are encouraging manufacturers to shift toward prebiotic-rich formulations. As a result, companies are expanding their use of oligosaccharide-based ingredients across food, dietary supplements, and pharmaceutical applications, further accelerating overall market development.
Key players operating in the Global Enzymatically Modified Oligosaccharides Market include Ingredion Incorporated, Cargill Incorporated, Kerry Group, Tate & Lyle PLC, DuPont (IFF), Yakult Honsha, Beneo GmbH, Roquette Freres, ADM, Baolingbao Biology Co., Ltd., and Samyang Corporation. Companies in the global enzymatically modified oligosaccharides market are strengthening their market position through product innovation, strategic collaborations, and capacity expansion. Leading players are investing in advanced enzymatic technologies to enhance product functionality, purity, and consistency while reducing production costs. Strategic partnerships with food and beverage manufacturers help accelerate the development of application-specific formulations tailored to gut health, sugar reduction, and functional nutrition trends.